期刊文献+

人卵巢癌高低侵袭潜能细胞系差异蛋白的初步分析 被引量:1

The Preliminary Analysis of Differentially Expressed Proteins with High & Low Invasive Potential in Human Ovarian Cancer Cell Lines
下载PDF
导出
摘要 目的:筛选与卵巢癌侵袭转移特性相关的蛋白质,为研究卵巢癌侵袭转移机制奠定基础。方法:将人卵巢癌细胞系SKOV-3在裸鼠体内多次传代,体外培养建系,结合细胞电泳速度、侵袭及移动实验筛选高、低侵袭潜能细胞亚系。采用表面增强激光解吸电离-飞行时间-质谱(SELDI-TOF-MS)检测二者的细胞裂解液,比较其蛋白质指纹图谱。结果:经过多次体内传代,结合体外实验筛选出细胞亚系SKOV-3F3,与其母系SKOV-3相比具有高侵袭潜能。比较二者蛋白质指纹图谱发现:6个差异蛋白质峰(质荷比M/Z分别为6249、14675、15425、15717、17123和17660)仅在SKOV-3中表达,3个差异蛋白质峰(M/Z分别为4355、4823和5763)仅在SKOV-3F3中表达,2个差异蛋白质峰(M/Z分别为1842和3145)均可在SKOV-3的3代亚系中捕获,但未在母系SKOV-3中发现。此外,5个差异蛋白质峰(M/Z分别为1242、5465、6899、6568和14027)在SKOV-3及其3代亚系中均可表达,但强度不同。结论:通过比较同一遗传背景的高、低侵袭潜能卵巢癌细胞的蛋白质指纹图谱,发现与侵袭潜能密切相关的差异蛋白质峰,对这些蛋白进行鉴定和功能验证有助于阐明卵巢癌侵袭转移机制。 Objective: To screen differentially expressed proteins that relate to the invasive and metastatic potential. Methods: Nude mice were intraperitoneally injected with the human ovarian cancer cell line SKOV-3. The metastatic tumors were removed and cultured in vitro. When the cell lines were established they were transplanted intraperitoneally for several cycles. The invasive potential of cell lines was evaluated by cell electrophoresis and Matrigel invasion assay. The enhanced surface laser desorption ionizing-flight time-mass spectra (ELDI-TOF-MS) was applied to detect the cell disruption solution and the protein fingerprints were compared. Results: SKOV-3F3, a cell line established after repeated in vivo passage, showed more highly invasive capacity than the parental SKOV-3 line in cell electrophoresis and Matrigel invasion assays. Based on the proteomic fingerprint patterns, we found six differelitially expressed proteins (6249, 14675, 15425, 15717, 17123 and 17660 at M/Z value) that were only expressed in SKOV-3. On the contrary, three distinct proteins (4355, 4823 and 5763 at M/Z value) were only expressed in SKOV,3F3. Furthermore, two differentially expressed proteins (1842 and 3145 at M/Z value) could only be detected in SKOV-3F1, SKOV-3F2 and SKOV-3F3. Five proteins (1242, 5465, 6899, 6568 and 14027 at M/Z value) were expressed in all SKOV-3, SKOV-3F1, SKOV-3F2 and SKOV-3F3 cell lines, but their abundance was different. Conclusion:These proteins expressed differentially between SKOV-3 and SKOV-3F3 are correlated with high invasive and metastatic potential. The identification of these proteins will help to clarify the invasion and metastasis mechanisms of ovarian cancer.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2006年第14期825-828,共4页 Chinese Journal of Clinical Oncology
基金 山东省科技厅科研基金资助(编号:2002BB1CJA9)
关键词 卵巢肿瘤 细胞系 侵袭转移 蛋白组学 差异蛋白 Tumor of the ovary Cell lines Invasion and metastasis Proteomics Differential protein
  • 相关文献

参考文献10

  • 1司徒镇强 吴军正.细胞培养[M].西安:世界图书版出版公司,2004.78-202.
  • 2Albini A,Iwamoto Y,Kleinman HK,et al.A rapid in vitro assay for quantitating the invasive potential of tumor cells[J].Cancer Res,1987,47(12):3239~3245
  • 3肖雪媛,刘丹慧,刘博,何大澄.体外培养的不同亚型肝癌细胞差异蛋白的初步筛查[J].解剖学报,2004,35(6):602-606. 被引量:9
  • 4Kiguchi K,Iwamori M,Mochizuki Y,et al.Selection of human ovarian carcinoma cells with high dissemination potential by repeated passage of the cells in vivo into nude mice,and involvement of Le(x)-determinant in the dissemination potential[J].Jpn J Cancer Res,1998,89(9):923~932
  • 5Jones MB,Krutzsch H,Shu H,et al.Proteomic analysis and identification of new biomarkers and therapeutic targets for invasive ovarian cancer[J].Proteomics,2002,2(1):76~84
  • 6Simone NL,Remaley AT,Charboneau L,et al.Sensitive immunoassay of tissue cell proteins procured by laser capture microdissection[J].AmJ Pathol,2000,156(2):445~452
  • 7Pandey A,Mann M.Proteomics to study genes and genomes[J].Nature,2000,405(6788):837~846
  • 8Simpson RJ,Dorow DS.Cancer proteomics:from signaling networks to tumor markers[J].Trends Biotechnol,2001,19(10suppl):40~48
  • 9何大澄,肖雪媛.SELDI蛋白质芯片技术在蛋白质组学中的应用[J].现代仪器,2002,38(1):1-4. 被引量:27
  • 10Issaq HJ,Veenstra TD,Conrads TP,et al.The SELDI-TOF MS approach to proteomics:protein profiling and biomarker identification[J].Biochem Biophys Res Commun,2002,292(3):587~592

二级参考文献15

  • 1[1]Adeela K,Angels A Q. ,James F,et al. Kinesin-mediated axonal transport of a membrane compartmnt containing beta-secretase and presenilin-lrequires. APP[J]Nature,2001,414:643~648
  • 2[2]Bichsel VE, Liotta LA, Petricoin Ef., Cancer Proteomics:from biomarker discovery to signal pathway profiling, Cancer J2001, 7 (1): 69~78
  • 3[3]Meerchant M et al, Recent advancemants in surface-enhanced laser desorption/ionization-time of flight-mass sepectrometry. Elecerephoresis, 2000, 21:1164~1177
  • 4[4]Steely HT Jr, Clark AF., The use of proteomics in ophthalmic research.: Pharmacogenomics 2000, 1 (3): 267~80
  • 5[5]Fung ET, Wright GL Jr, Dalmasso EA., Proteomic strate gies for biomarker identification: progress and challenges,Curr Opin Mol Ther 2000, 2 (6) :643~50
  • 6[6]Simone NL, Paweletz CP, Charboneau L, Petricoin EF, Liot ta LA., Laser capture microdissection: beyond functional ge nomics to proteomics, Mol Diagn 2000, 5 (4): 301~7
  • 7[7]Cordon-Cardo C, Cote RJ, Sauter G., Genetic and molec ular markers of urothelial premalignancy and malignancy,Scand J Urol Nephrol Suppl 2000, (205): 82~93
  • 8[8]Von Eggeling F, Davies H, Lomas L, Fiedler W, Junker K, Claussen U, Ernst G., Tissue-specific microdissection coupled with ProteinChip array technologies: applications in cancer research. Biotechniques 2000, 29 (5):1066~70
  • 9[9]Lopez MF, Kristal BS, Chemokalskaya E, Lazarev A,Sheaopalov AI, Bogdanova A, Robinson M., High-throughput profiling of the mitochondrial proteome using affinity fractionation and automation, Electrophoresis 2000, 21 (16): 3427~40
  • 10[10].Chambers G, Lawrie L, Cash P, Murray GI.,Proteomies:a new approach to the study of disease,J Pathol 2000;192(3):280-8

共引文献315

同被引文献8

  • 1Jain D, Srinivasan R, Patel FD, et al. Evaluation of p53 and Bd--2 expression as prognostic markers ha invasive cervical carcinoma stage Ⅱb/Ⅲ patients treated by radiotherapy[J]. Gynecol Oncol, 2003, 88(1): 22-28.
  • 2Bachtiary B, Schindl M, Potter R, et al. Overexpression of hypoxia-inducible factor lalpha indicates diminished response to radiotherapy and unfavorable prognosis in patients receiving radical radiotherapy for cervical cancer[J]. Clin Cancer Res, 2003, 9(6): 2234--2240.
  • 3Sinha TK, Khatib--Shahidi S, Yankeelov TE, et al. Integrating spatially resolved three-dimensional MALDI IMS with in vivo magnetic resonance imaging[J]. Nat Methods, 2008, 5(1): 57-59.
  • 4Lin YW, Lai HC, Lin CY, et al. Plasma proteomic profiling for detecting and differentiating in situ and invasive carcinomas of the uterine cervix[J]. Int J Gynecol Cancer, 2006, 16(3): 1216-1224.
  • 5Bae SM, Lee CH, Cho YL, et al. Two--dimensional gel analysis of protein expression profile in squamous cervical cancer patients [J]. Gynecol Oncol, 2005, 99(1): 26-35.
  • 6林英姿,陈仁,杨文,李翠,罗鸣,卢伟英.人宫颈癌组织及癌旁正常组织蛋白质组的比较研究[J].第四军医大学学报,2007,28(17):1593-1596. 被引量:4
  • 7朱峰,吕顺莉,高军,龚燕芳,李兆申.人胰腺癌胰液蛋白质差异表达分析[J].中国肿瘤临床,2008,35(5):265-268. 被引量:6
  • 8朱红,曾亮,涂青松,肖自强.S100A9 Galectin7在同时放化疗敏感性不同宫颈癌中的表达及意义[J].中国肿瘤临床,2008,35(5):277-280. 被引量:3

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部